National and international leading researchers have addressed this Monday and Tuesday the main scientific advances and challenges in the areas of bioengineering, biomaterials and nanomedicine. For yet another year, the XIV CIBER-BBN Annual Conference, held online, has brought together all the scientific groups in this area of the ISCIII Center for Online Biomedical Research (CIBER).
The conference was opened on Monday by the director of the ISCIII, Raquel Yottti, who highlighted the role of the CIBER-BBN investigation “to find answers to very complex problems, specifically this year in the field of the fight against the pandemic.” The scientific director of the CIBER-BBN, Ramón Martínez Máñez, highlighted the good results in scientific production of the groups at the center, the importance of internationalization and the high number of requests for European projects.
Internal collaborations and projects with CIBEREHD
This edition of the conference has included presentations of internal collaboration projects, three plenary talks given by renowned experts in the fields of Hybrid Biosignals and Nanomaterials Analysis, a forum on the main achievements of ICTS Nanbiosis, and a session dedicated to COVID- 19 and the most recent advances in fighting disease in detection, prevention, and therapy.
The conference began on Monday with two internal collaboration sessions, in which topics such as hybrid (nano) materials for biomedical applications, molecular and metabolic biomarkers in bladder cancer for new detection and treatment strategies or technologies based on in proteins for targeted tumor cell therapy.
She also highlighted the collaboration in these conferences of the CIBER on Liver and Digestive Diseases (CIBEREHD), thanks to the participation of María Luz Martínez, from CIC BIOGUNE. In this session, the seed projects were discussed in collaboration between the two areas.
Session on COVID-19
During the day of the 17th, the first part has been dedicated to COVID-19. Jordi Vila, from the Institute of Global Health and Hospital Clínic de Barcelona, spoke about the ‘Evolution of the clinical microbiological diagnosis of COVID-19 during the pandemic’, while Julià Blanco, from the IrsiCaixa AIDS Research Institute of Barcelona, has fact about the ‘Immune responses to SARS-CoV-2 infection and vaccination’. For her part, Nuria Oliver, curator of the Presidency of the Valencian Community, has focused on ‘Data science to fight COVID-19’.
The conference closed this Tuesday with two sessions on internal collaborations and another on Nanbiosis, the ICTS of the CIBER-BBN, Bionand and the Jesús Usón Center for Minimally Invasive Surgery (CCMIJU) .
Source of information: ISCIII